Market Tracker

05/27 5:16pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

6.31
Delayed Data
As of May 27
 -0.23 / -3.52%
Today’s Change
5.02
Today|||52-Week Range
13.00
-20.13%
Year-to-Date

Today’s Trading

Previous close6.54
Today’s open6.45
Day’s range6.08 - 6.46
Volume2,475,844
Average volume (3 months)1,925,978
Market cap$883.9M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-66.25%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-13.14%
P/E ratioNM
Price/Sales9.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.03+0.43%
LCILannett Company Inc+0.78+3.40%
SRPTSarepta Therapeutics...-1.01-4.55%
ZIOPZIOPHARM Oncology In...+0.33+4.67%
Data as of 4:01pm ET, 05/27/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$89.3M
Annual profit (last year)-$148.0M
Net profit margin-165.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts